ACTI — Active Biotech AB publ Share News
0.000.00%
Last trade - 00:00- SEK367.52m
- SEK314.32m
Brief: Active Biotech Announces New Direction
Brief: Active Biotech AB Q3 Operating Loss Widens To SEK 9.3 Mln
Brief: Active Biotech: New Data On Laquinimod From Phase 2 LEGATO-HD Study
Brief: Active Biotech Q2 Operating Loss Narrows To SEK 5.4 Million
Brief: Active Biotech: Election Committee Proposes Michael Shalmi As Chairman
Brief: Active Biotech Q1 Operating Loss Narrows To SEK 6.4 Mln
Brief: Active Biotech Has Entered Into An Agreement Regarding Sale Of Company's property
Brief: Active Biotech Q4 Operating Loss Sek 7.1 Million
Brief: Active Biotech Partner NeoTX Enters Clinical Collaboration With AstraZeneca
Brief: Active Biotech Receives Bid For Property In Lund
Brief: Active Biotech Updates On Financial Position
Swedish stocks: Seen opening higher, Atlas Copco confirms outlook
Brief: Active Biotech Reports Qtrly Net Sales SEK 4.7 Million
Brief: Active Biotech says new data from the phase 2 Legato-HD study will be presented at HSG 2018
Brief: Active Biotech Regains Global Rights To Development And Commercialization Of Laquinimod
Swedish stocks: Seen opening flat, Hexagon CEO sells half his stake in the company
Brief: Active Biotech says Q2 operating loss falls to 7.3 MSEK
Brief: Active Biotech Provides Update On Laquinimod In Huntington's Disease
Active Biotech: Slumps by a third after key trial update